US clinical-stage development and manufacturing company Phage Pharmaceuticals has appointed David Jackson VP of operations planning. He will be responsible …
AstraZeneca’s Trixeo approved in EU for asthma
ESTEVE CDMO adds $17.5m to Illinois expansion

